Promising trials of a new antibiotic drug trademarked as Zaynich – meant to act against all major superbugs – has triggered a sharp run-up in the Wockhardt stock. It has jumped nearly 75% in less than a month as the Street steadily factored in the immense opportunity that could open for the drug once launched … Read more
The makers of Ozempic say their weight-loss drug Wegovy will be available to patients in Canada starting Monday. Novo Nordisk’s weekly injection is approved for weight loss among patients diagnosed with obesity. Wegovy can also be prescribed to patients who are significantly overweight and have at least one related medical condition such as high blood pressure, Type 2 … Read more
Descrease article font size Increase article font size Canadians will be able to get their hands on Wegovy, a weight-loss drug from Ozempic-maker Novo Nordisk, in spring 2024, the company said Monday. Wegovy was first approved by Health Canada in 2021 but hasn’t been accessible due to high demand and an ongoing supply shortage. At … Read more
